XML 37 R21.htm IDEA: XBRL DOCUMENT v3.25.1
Revenue
 12 Months Ended
Dec. 31, 2024
Revenue [Abstract]  
REVENUE

13. REVENUE

 

We primarily offer the First DefenseÒ product line to dairy and beef producers to prevent scours in newborn calves. Generally, our products are promoted to veterinarians as well as dairy and beef producers by our sales team and then sold through distributors. Our primary market is North America. We do sell into select international regions and may expand this international reach in the future. There were no material changes between the allocation and timing of revenue recognition during the years ended December 31, 2024 or 2023. We do not have any contract assets for which we have satisfied the performance obligations, but do not yet have the right to bill for, or contract liabilities such as customer advances. All trade receivables on our balance sheets are from contracts with customers. We incur no material costs to obtain contracts.

 

The following table presents our product sales disaggregated by geographic area:

 

   During the Years Ended December 31, 
   2024   %   2023   % 
United States  $22,893,721    86%   $15,949,382    91% 
Other   3,599,448    14%    1,522,287    9% 
Total Product Sales  $26,493,169    100%   $17,471,669    100% 

 

The following table presents our product sales disaggregated by major product category:

 

   During the Years Ended December 31, 
   2024   %   2023   % 
First Defense® product line  $26,314,250    99%   $17,293,933    99% 
Other animal health   178,919    1%    177,736    1% 
Total Product Sales  $26,493,169    100%   $17,471,669    100%